Deutsche Bank’s Repros Therapeutics Inc. RPRX Stock Holding History

Deutsche Bank’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-500	Closed	-$4K	–	5696
2015 Q1	$4K	Sell	500 -10,740	-96%	-$96.1K	﹤0.01%	4944
2014 Q4	$112K	Buy	11,240 +635	+6%	+$5.42K	﹤0.01%	4659
2014 Q3	$104K	Buy	10,605 +9,981	+1,600%	+$148K	﹤0.01%	4484
2014 Q2	$10K	Sell	624 -1,150	-65%	-$18.7K	﹤0.01%	5519
2014 Q1	$2K	Buy	1,774 +1,532	+633%	+$29.6K	﹤0.01%	5400
2013 Q4	$1K	Sell	242 -9,138	-97%	-$173K	﹤0.01%	5364
2013 Q3	$10K	Buy	9,380 +5,978	+176%	+$128K	﹤0.01%	5057
2013 Q2	$5K	Buy	+3,402	New	+$60.1K	﹤0.01%	5049

Other funds holding RPRX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GAI

General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return

AIA

Allegis Investment Advisors Idaho Falls, Idaho $326M AUM 10.36% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Deutsche Bank's RPRX Position: Q4 2016 in Review

Deutsche Bank sold out of Repros Therapeutics Inc. (RPRX) in Q4 2016, closing a stake of 2,446 shares — an estimated $5K sold.

Deutsche Bank first reported a position in RPRX in Q2 2013 and held it in 14 quarters. The position peaked at $1.74M in Q2 2013. 43 funds tracked by Wall St. Rank hold RPRX as of Q4 2016.

Deutsche Bank reported no remaining Repros Therapeutics Inc. position as of Q4 2016 after selling out during the quarter.
Deutsche Bank sold 2,446 Repros Therapeutics Inc. shares in Q4 2016, an estimated $5K.
Deutsche Bank first reported a position in Repros Therapeutics Inc. in Q2 2013 and held it in 14 quarters.
Deutsche Bank's Repros Therapeutics Inc. position peaked at $1.74M in Q2 2013.
43 funds tracked by Wall St. Rank held Repros Therapeutics Inc. as of Q4 2016.

Based on Deutsche Bank's 13F filing for Q4 2016, filed 14 Feb 2017.